Lepu Medical Technology (Beijing) Co., Ltd.
SZSE:300003.SZ
16.85 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 7,883.085 | 10,609.442 | 10,659.735 | 8,038.668 | 7,795.529 | 6,356.305 | 4,537.643 | 3,467.748 | 2,768.717 | 1,668.637 | 1,303.268 | 1,015.92 | 919.846 | 770.101 | 565.197 | 393.879 | 298.985 | 175.338 |
Cost of Revenue
| 3,176.968 | 3,983.286 | 4,156.637 | 2,653.774 | 2,165.195 | 1,732.194 | 1,486.914 | 1,354.141 | 1,236.937 | 608.276 | 403.774 | 212.033 | 160.642 | 131.529 | 103.249 | 84.386 | 74.198 | 50.942 |
Gross Profit
| 4,706.117 | 6,626.156 | 6,503.098 | 5,384.894 | 5,630.334 | 4,624.111 | 3,050.729 | 2,113.607 | 1,531.781 | 1,060.361 | 899.493 | 803.888 | 759.204 | 638.572 | 461.948 | 309.494 | 224.787 | 124.396 |
Gross Profit Ratio
| 0.597 | 0.625 | 0.61 | 0.67 | 0.722 | 0.727 | 0.672 | 0.61 | 0.553 | 0.635 | 0.69 | 0.791 | 0.825 | 0.829 | 0.817 | 0.786 | 0.752 | 0.709 |
Reseach & Development Expenses
| 800.744 | 957.062 | 907.941 | 736.134 | 543.914 | 376.171 | 234.75 | 168.645 | 110.114 | 73.021 | 72.339 | 53.626 | 32.843 | 26.964 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 270.515 | 224.379 | 293.524 | 178.386 | 211.259 | 185.549 | 115.474 | 86.386 | 70.475 | 37.991 | 44.328 | 31.365 | 22.029 | 18.17 | 57.654 | 40.816 | 33.989 | 12.963 |
Selling & Marketing Expenses
| 1,624.614 | 2,033.686 | 2,109.191 | 1,838.783 | 2,171.677 | 1,868.58 | 1,061.775 | 638.057 | 432.171 | 341.342 | 296.827 | 226.093 | 148.527 | 114.341 | 82.429 | 70.474 | 45.647 | 29.699 |
SG&A
| 2,225.302 | 2,258.064 | 2,402.715 | 2,017.169 | 2,382.937 | 2,054.128 | 1,177.249 | 724.443 | 502.646 | 379.333 | 341.155 | 257.458 | 170.555 | 132.51 | 140.082 | 111.29 | 79.635 | 42.662 |
Other Expenses
| -114.188 | 552.19 | 489.081 | 457.581 | 443.106 | 31.468 | 39.759 | 28.991 | 20.017 | 20.109 | 11.018 | 13.478 | 5.582 | 3.351 | 3.948 | 1.19 | 0.811 | -0.433 |
Operating Expenses
| 3,140.234 | 3,767.317 | 3,799.737 | 3,210.884 | 3,369.956 | 2,829.898 | 1,725.413 | 1,163.224 | 810.229 | 542.47 | 483.293 | 362.633 | 248.688 | 189.494 | 141.266 | 111.492 | 79.989 | 44.5 |
Operating Income
| 1,565.883 | 2,623.139 | 2,144.602 | 2,149.178 | 2,761.256 | 1,442.443 | 1,155.709 | 864.215 | 684.035 | 516.864 | 420.969 | 466.463 | 537.421 | 469.346 | 327.481 | 200.515 | 149.504 | 79.939 |
Operating Income Ratio
| 0.199 | 0.247 | 0.201 | 0.267 | 0.354 | 0.227 | 0.255 | 0.249 | 0.247 | 0.31 | 0.323 | 0.459 | 0.584 | 0.609 | 0.579 | 0.509 | 0.5 | 0.456 |
Total Other Income Expenses Net
| 12.976 | -11.357 | 1.55 | 54.136 | -698.001 | -320.302 | -129.848 | -59.421 | -20.612 | 18.747 | 15.759 | 38.576 | 32.487 | 23.57 | 10.741 | 3.703 | 5.517 | -0.39 |
Income Before Tax
| 1,578.859 | 2,611.782 | 2,146.152 | 2,203.313 | 2,063.256 | 1,473.911 | 1,195.468 | 890.963 | 700.94 | 536.638 | 431.959 | 479.83 | 543.003 | 472.648 | 331.423 | 201.704 | 150.315 | 79.506 |
Income Before Tax Ratio
| 0.2 | 0.246 | 0.201 | 0.274 | 0.265 | 0.232 | 0.263 | 0.257 | 0.253 | 0.322 | 0.331 | 0.472 | 0.59 | 0.614 | 0.586 | 0.512 | 0.503 | 0.453 |
Income Tax Expense
| 262.147 | 367.094 | 365.733 | 326.235 | 339.464 | 219.037 | 201.788 | 144.255 | 104.949 | 84.402 | 65.309 | 76.503 | 69.845 | 62.007 | 39.065 | 0.535 | 0.589 | 15.905 |
Net Income
| 1,258.2 | 2,203.779 | 1,719.325 | 1,801.933 | 1,725.306 | 1,218.693 | 899.085 | 679.256 | 520.891 | 423.193 | 361.645 | 403.273 | 473.158 | 410.483 | 292.212 | 201.368 | 149.726 | 63.6 |
Net Income Ratio
| 0.16 | 0.208 | 0.161 | 0.224 | 0.221 | 0.192 | 0.198 | 0.196 | 0.188 | 0.254 | 0.277 | 0.397 | 0.514 | 0.533 | 0.517 | 0.511 | 0.501 | 0.363 |
EPS
| 0.68 | 1.22 | 0.96 | 1.01 | 0.97 | 0.68 | 0.51 | 0.39 | 0.32 | 0.26 | 0.22 | 0.25 | 0.29 | 0.25 | 0.19 | 0.14 | 0.12 | 0.13 |
EPS Diluted
| 0.68 | 1.21 | 0.95 | 1.01 | 0.97 | 0.68 | 0.51 | 0.39 | 0.32 | 0.26 | 0.22 | 0.25 | 0.29 | 0.25 | 0.19 | 0.14 | 0.12 | 0.13 |
EBITDA
| 2,169.66 | 3,361.588 | 2,842.835 | 2,916.037 | 3,045.747 | 2,238.645 | 1,567.66 | 1,162.603 | 897.796 | 618 | 497.483 | 483.425 | 571.813 | 492.273 | 344.896 | 211.566 | 151.432 | 82.167 |
EBITDA Ratio
| 0.275 | 0.317 | 0.267 | 0.363 | 0.391 | 0.352 | 0.345 | 0.335 | 0.324 | 0.37 | 0.382 | 0.476 | 0.622 | 0.639 | 0.61 | 0.537 | 0.506 | 0.469 |